A mother from Wiltshire with Multiple Sclerosis is trying to raise £30,000 for groundbreaking treatment that she hopes will change her life. Leanda Alatoum, who has six children, was diagnosed with MS three years ago, leaving her with vision ... ITV.com, 6 hours ago
Animal research, Health, Scientific progress 21 - 07 - 2016 INSERM researchers in Caen have developed in mice a new antibody capable of treating multiple sclerosis. > Click here to view video. Multiple sclerosis (MS) is ...Recherche Animale, 3 hours ago Multiple Sclerosis Drug Could Be Effective Target for Parkinson's Disease Treatment HCPLive, 4 days ago Researchers develop antibody with potential therapeutic effects against multiple sclerosis News-Medical.Net, 5 days ago An antibody-based drug for multiple sclerosis EurekAlert!, 5 days ago
A multiple sclerosis sufferer in England travelling to Germany for potentially life-changing treatment saw her dash to Dover turn into a 20-hour ordeal. Tanya Cudworth, 50, was travelling to a Frankfurt clinic to undergo stem cell treatment for ...Breaking News.ie, 1 day ago Disabled woman travelling through Dover for radical treatment delayed for 20 HOURS Scottish Daily Express, 1 day ago
The European Medicines Agency (EMA) has granted the review of the Marketing Authorisation Application (MAA) for American pharmaceutical company Merck's investigational product Cladribine Tablets to treat relapsing-remitting multiple sclerosis (MS). ...Pharmaceutical Technology, 6 days ago
Learn what you can do to help a loved one with multiple sclerosis deal with medical tests and treatments. Medical tests and doctors' appointments are a regular part of life for people living with multiple sclerosis (MS) . Your loved one will ...EverydayHealth.com, 6 days ago Medical marijuana becomes legal in Macedonia Asian Age, 1 month ago Clinical Trials For New Alzheimer's Medication HealthMediciNet.com, 5 days ago History in Medical Education and the Roots of Knowledge HealthMediciNet.com, 5 days ago
Paralysis is a life changing condition that can be caused by medical conditions like multiple sclerosis, but in many cases results from a traumatic accident or injury that leaves the person with a spinal cord, head, and/or brain injury. Repairing ...National Law Review, 2 hours ago
Health Care Resource Use and Costs of H.P. Acthar Gel Repository Corticotropin Injection for Multiple Sclerosis Relapse
By a News Reporter-Staff News Editor at Drug Week Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, announced new retrospective health economic data on H.P. Acthar() Gel (repository corticotropin injection; RCI), ...Pharmacy Choice, 3 days ago "Treatment of Multiple Sclerosis by Alemtuzumab Induction Followed by Laquinimod Therapy" in Patent Application Approval Process (USPTO 20160184428) Pharmacy Choice, 5 days ago Researchers Submit Patent Application, "Antibodies to Interleukin-6 and Use Thereof", for Approval (USPTO 20160185851) Pharmacy Choice, 4 days ago
Data from University Hospital Advance Knowledge in Multiple Sclerosis [Description of the Characteristics of Multiple Sclerosis Patients in the...
Data from University Hospital Advance Knowledge in Multiple Sclerosis [Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 ...] ...Pharmacy Choice, 6 hours ago Understanding and Coping With MS Flares EverydayHealth.com, 6 days ago fasting cycle could reduce multiple sclerosis symptoms HCPLive, 1 week ago alleviating multiple sclerosis symptoms possible with yoga and aquatic exercises HCPLive, 1 week ago
PCORI Board Approves $153 Million to Support Patient-Centered Comparative Clinical Effectiveness Research
From the Wires Awards Include Research on Opioids, Depression, Multiple Sclerosis and Blood Clots Jul. 19, 2016 02:53 PM WASHINGTON, DC--(Marketwired - July 19, 2016) - The Patient-Centered Outcomes Research Institute (PCORI) Board of ...Sys-Con India, 5 days ago
Merck KGaA MKGAF announced that its Marketing Authorisation Application (MAA) for cladribine has been accepted by the European Medicines Agency (EMA) for review for the treatment of relapsing-remitting multiple sclerosis (MS). We note that last ...Yahoo! Singapore, 6 days ago
More from: , Zacks.com...and 2 other sources
on your WebpageAdd Widget >Get your members hooked!